Effect of beta-adrenergic blocking compounds on tissue catecholamine levels.
D000083:Acetanilides / Q000494:pharmacology; D000311:Adrenal Glands / Q000032:analysis* / Q000187:drug effects; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000498:Allyl Compounds / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D001923:Brain Chemistry; D002395:Catecholamines / Q000032:analysis*; D004298:Dopamine / Q000032:analysis; D004837:Epinephrine / Q000032:analysis; D006321:Heart / Q000187:drug effects; D008297:Male; D009206:Myocardium / Q000032:analysis*; D009638:Norepinephrine / Q000032:analysis; D009929:Organ Size; D010636:Phenols / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013565:Sympatholytics / Q000494:pharmacology*
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000498:Allyl Compounds; D000605:Amino Alcohols; D002395:Catecholamines; D010636:Phenols; D011437:Propylamines; D013565:Sympatholytics; D011433:Propranolol; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine